Project Grant R21AT013666
- Federal Grant Award Summary The University of California, San Diego received a $638,334 Project Grant award dated September 8, 2025, through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) to develop innovative computational drug design technologies. The project, scheduled for completion by August 31, 2027, focuses on advancing understanding of protein-small molecule binding mechanisms by creating novel computational...
- Federal Grant Award Summary The University of California, San Diego received a $423,975 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award supports fundamental research focused on the discovery and application of halogenases—enzymes capable of installing halogen atoms (fluorine, chlorine, bromine, and iodine) onto organic compounds...
- Federal Grant Award Summary The University of California, San Francisco received a $501,000 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 5, 2025, with completion expected May 31, 2030. This five-year research initiative focuses on bridging the gap between predicted and experimentally determined atomic structures in structural biology. The project will develop...
- Federal Grant Award Summary The University of California, San Diego received a $347,086 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025, through August 31, 2030. This award funds a five-year research initiative focused on developing precision, functional glyconanoassemblies through supramolecular design. The research aims to advance synthetic glycan assembly...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $150,104 to the University of California, San Diego under the Biomedical Research and Research Training program (CFDA 93.859) for the period of March 1, 2026 through December 31, 2028. This project grant supports the de novo design of artificial haloperoxidase enzymes—specifically vanadium- and heme-dependent haloperoxidases—using machine-learning tools for protein design and structure...
- Federal Project Grant Award Summary This $147,000 Project Grant, awarded September 1, 2025, through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports fundamental research on alpha ketoglutarate-dependent dioxygenase enzymes to be conducted at California State University, San Bernardino through August 31, 2029. The research deliverables include mechanistic and structural characterization of two flavonoid-producing...
- Federal Grant Award Summary The University of California, Davis received a $450,060 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on June 6, 2025, with completion targeted for December 5, 2026. The project delivers fundamental research services focused on spectroscopic characterization of enzymatic intermediates containing iron-sulfur clusters. The research employs advanced...
- Federal Project Grant Award Summary The University of California, San Diego received a $327,019 Project Grant award dated July 25, 2025, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports research through April 30, 2030, focusing on developing innovative biophysical and computational frameworks to understand how cells transform during embryogenesis and stem cell differentiation. The...
- Federal Project Grant Award Summary The University of California, San Diego received a $370,550 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded May 1, 2026, with completion targeted for February 28, 2031. This research initiative develops the Intracellular Protein Organization Landscape (IPOL), a quantitative computational framework designed to characterize cell types and states based...
- Federal Project Grant Award Summary The University of California, San Diego received a $788,967 Project Grant award dated April 16, 2026, from the National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). This five-year research initiative, extending through March 31, 2031, will investigate the effects and mechanisms by which psilocybin induces pain relief in patients with chronic phantom limb...
The University of California, San Diego received a $439,500 Project Grant from the National Center for Complementary and Integrative Health under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) for the period April 1, 2026 through March 31, 2028. The award supports the development of advanced technologies and methodologies to enable high-resolution structural analysis of native polyketide synthase (PKS) megasynthases using cryo-electron microscopy (cryo-EM). The research addresses significant technical barriers in structural biology by developing two critical tools: first, methods to convert native holo-PKS to their cognate apo-forms to enable crosslinking within native PKS systems, and second, protein isolation methodologies for very large megasynthases (500 kilodaltons to 2 megadaltons) extracted directly from native producer organisms' proteomes. The project utilizes the amphotericin synthase pathway from Streptomyces nodosus as a model system to validate these technologies and demonstrate their applicability to polyketide natural products research. By developing dual site-selective crosslinking tools that enforce dynamic constraints on these highly flexible megaproteins, the research aims to achieve previously unattainable high-resolution cryo-EM structures of complete, native synthase complexes. These deliverables represent a fundamental advancement in molecular-level understanding of PKS structure and function, with direct applications to polyketide-based drug discovery and manufacturing.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $439.5k | 3/26/26 |